AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (1.9 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Review | Open Access

Multi-omics insights into bone tissue injury and healing: bridging orthopedic trauma and regenerative medicine

Liyu Yang1,‡, Zhijie Xu1,‡, Jie Liu1,2, Xiyue Chang1,2, Zhaozhou Ren1( ), Wan’an Xiao1 ( )
Department of Orthopedics, Shengjing Hospital of China Medical University, 36 Sanhao Street, Heping District, Shenyang, Liaoning 110004, China
Department of Epidemiology, School of Public Health, China Medical University, 77 Puhe Road, Shenbei New District, Shenyang, Liaoning 110013, China

‡Liyu Yang and Zhijie Xu are co-first authors and contributed equally to this paper.

Show Author Information

Highlights

• Three-dimensional cultures of osteogenic and chondrogenic cells provide a tissue engineering approach that mimics bone and cartilage in vitro, offering new insights into bone and cartilage regeneration.

• Polymer-based drug delivery systems show promise for bone tissue regeneration, with ongoing research exploring their progress, prospects, and potential applications.

• Strontium functionalization of biomaterials enhances osteogenic differentiation, making them a promising option for bone tissue engineering purposes.

• Multi-omics approaches, including materiomics and mechanomics, offer new perspectives for understanding bone biology and engineering bone tissue, with implications for regenerative medicine and disease treatment.

• The integration of clinical phenomes with molecular multi-omics, known as clinical trans-omics, presents a comprehensive approach for understanding and treating complex bone diseases, offering new avenues for personalized medicine.

Abstract

To preserve functionality, bone is an active tissue that can constantly reconstruct itself through modeling and remodeling. It plays critical roles in the body, including maintaining mineral homeostasis, serving as the adult human body’s core site of hematopoiesis, and supporting the structures of the body’s soft tissues. It possesses the natural regeneration capacity, but large and complex lesions often require surgical intervention. Multiple omics integrate proteomics, metabolomics, genomics, and transcriptomics to provide a comprehensive understanding of biological processes like bone tissue injury and healing in bone tissue regeneration and engineering. Recently, bone tissue engineering and regenerative medicines have offered promising tools for bone regeneration using a multi-omics approach. Thus, this article will highlight the role of multiple omics in understanding bone tissue injury and healing. It will discuss the role of bone tissue engineering in developing bone substitutes that can replace translational medicine. Lastly, new developments in bone tissue engineering and regenerative medicine, along with multi-omics approaches, offer promising tools for bone regeneration.

References

【1】
【1】
 
 
Burns & Trauma
Article number: tkaf019

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
Yang L, Xu Z, Liu J, et al. Multi-omics insights into bone tissue injury and healing: bridging orthopedic trauma and regenerative medicine. Burns & Trauma, 2025, 13(6): tkaf019. https://doi.org/10.1093/burnst/tkaf019

2

Views

0

Downloads

0

Crossref

0

Web of Science

0

Scopus

Received: 27 April 2024
Revised: 18 June 2024
Accepted: 27 February 2025
Published: 10 October 2026
© The Author(s) 2025. Published by Oxford University Press.

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com